Studies analyzing the effects of other drugs such as DPP-4
There is a theoretical concern (and some limited clinical evidence) that high-dose antioxidants like ALA could reduce the efficacy of these treatments
That often looks like: improved mood more follow-through with workouts less fatigue after work better motivation If fatigue has been your most significant issue, this is often when the benefits are most apparent
Keywords: immune checkpoint inhibitors, adverse events, anti-PD-1, anti-PD-L1, anti-CTLA-4, efficacy, survival, correlation Correspondence to: Omar Abdihamid Email: [email protected] Published: 02/11/2021 Received: 07/03/2021 Publication costs for this article were supported by e cancer (UK Charity number 1176307)
Anyone participating in a clinical trial who experiences persistent or severe gastrointestinal symptoms, unexplained abdominal pain (which may indicate pancreatitis or gallbladder disease), signs of dehydration, or other concerning symptoms should contact their supervising healthcare team promptly
